1. 1) Goto N, Suda N, Shiraishi T, Komoda M, Nakayama K, Sugiyama T, Yamakawa M, Masada M. Annual report of the Fourth Sciences Subcommittee of the Japanese Society of Hospital Pharmacist 2003: Approach toward the commercialization of hospital preparations. Journal of the Japanese Society of Hospital Pharmacists, 40, 1024–1027 (2004).
2. 2) Lyman GH, Giuliano AE, Somerfield MR, Benson AB 3rd, Bodurka DC, Burstein HJ, Cochran AJ, Cody HS 3rd, Edge SB, Galper S, Hayman JA, Kim TY, Perkins CL, Podoloff DA, Sivasubramaniam VH, Turner RR, Wahl R, Weaver DL, Wolff AC, Winer EP. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J. Clin. Oncol., 23, 7703–7720 (2005).
3. 3) Watanabe K, Nomura K, Otsu F, Goto N, Suda N, Matsuura K, Miyazaki Y, Yamakawa K, Yamaguchi M, Watanabe K, Nakamura T, Masada M. Survey on usage of dye pharmaceutical preparations in sentinel lymph node biopsy. Japanese Journal of Pharmaceutical Health Care and Sciences, 35, 722–728 (2009).
4. 4) Ashford RF, Plant GT, Maher J, Pickering D, Coe MA, Drury A, Goold MA, Teare EL. Metronidazole in smelly tumours. Lancet, 1, 874–875 (1980).
5. 5) Symptom relief in terminal illness. The World Health Organization (WHO). Geneva, pp. 88–98 (1998).